Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Andrew Stewart
ID:
1b839057-2619-30fb-68c4
/
Claimed Record
/
Organization:
Rothwell Figg
Published Works
2 articles
Continued Investment in AI Drug Discovery Points to Potential Future Significance of Inventorship in Biosimilar Litigation
Biosimilars Law Bulletin ·
December 20, 2024
cite
New BPCIA Case Filed: Genentech and Biogen Want to Stop Dr. Reddy’s Rituximab Biosimilar from Entering the U.S. Market
Biosimilars Law Bulletin ·
December 1, 2023
cite
Practice Areas
Health Care and Life Sciences
Jurisdictions
North America
United States
Washington, D.C.
